[ad_1]
Spindletop Health Acquisition Corp. (NASDAQ: SHCA)
AUSTIN, TX, USA, November 8, 2021 /EINPresswire.com/ – Spindletop Health Acquisition Corp. (the “Company”) today announced the completion of its initial public offering of 23,000,000 units at a price of $ 10.00 per unit, including 3,000,000 units issued upon the full exercise by the underwriters of their over-allotment option. The shares are listed on the NASDAQ Stock Market and traded on November 4, 2021 under the ticker symbol “SHCAU”. Each share consists of one share of the company’s Class A common stock and one half of a redeemable warrant. Each entire warrant entitles its holder to purchase one Class A common share at a price of $ 11.50 per share. Only whole warrants can be exercised. Once the securities making up the Units commence separate trading, the Company expects its common stock and Class A warrants to be listed on NASDAQ under the symbols “SHCA” and “SHCAW”, respectively.
The company was formed for the purpose of a merger, an exchange of capital, an acquisition of assets, a share purchase, a restructuring or a similar business combination with one or more companies. The company’s efforts to identify a potential target company will not be limited to any particular industry or geographic region, although it intends to focus on identifying, acquiring, and building an undervalued, growth-oriented company in the healthcare services sector.
Barclays and Stifel acted as joint accounting managers.
The public offer was made exclusively by means of a prospectus. Copies of the final prospectus relating to the offering are available from Barclays Capital Inc., c / o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by calling 1-888-603-5847 or emailing Barclaysprospectus @ broadridge.com; or Stifel, Nicolaus, & Company, Incorporated, 1 South Street, 15th Floor, Baltimore, Maryland 21202, Attn: Prospectus Department, or by email at syndprospectus@stifel.com.
The registration statements for the securities took effect on November 3, 2021. This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will any sale of these securities be made in any state or jurisdiction in which such offer, solicitation or sale would be prior to registration or qualification under any securities laws Unlawful state or such jurisdiction.
Forward-Looking Statements
This press release contains statements that constitute “forward-looking statements,” including regarding the proposed IPO and the expected use of the net proceeds therefrom. No assurance can be given that the net proceeds of the offer will be used as stated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the company, including those set out in the Risk Factors section of the company’s registration statement and the prospectus for the company’s offering filed with the Securities and Exchange Commission ( The S “). Copies of these documents are available on the SEC’s website at www.sec.gov. The company assumes no obligation to update these statements for revisions or changes after the date of this publication unless required by law .
Attention: Investor Relations
Spindletop Health Acquisition Corp.
+1 512-961-4633
info (at) spindeltophealth.com
You just read:
News provided by
November 08, 2021, 21:00 GMT
EIN Presswire’s priority is source transparency. We don’t allow opaque clients, and our editors try to carefully weed out false and misleading content. If, as a user, you notice something that we have overlooked, please make us aware of it. Your help is welcome. ONE Presswire, Everyone’s Internet News Presswire ™, seeks to define some of the boundaries that are appropriate in the world today. Please see our editorial guidelines for more information.
Submit your press release
[ad_2]
https://www.einnews.com/pr_news/555710732/spindletop-health-acquisition-corp-announces-closing-of-230-million-initial-public-offering
